BPL-003 Efficacy and Safety in Treatment Resistant Depression
- First Posted Date
- 2023-05-23
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- Beckley Psytech Limited
- Target Recruit Count
- 196
- Registration Number
- NCT05870540
- Locations
- πͺπΈ
Hospital del Mar, Barcelona, Spain
πͺπΈCentro Salud San Juan, Salamanca, Spain
πͺπΈParc Sanitari Sant Joan de Deu HD Numancia, Barcelona, Spain
An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder
- First Posted Date
- 2023-01-09
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Beckley Psytech Limited
- Target Recruit Count
- 12
- Registration Number
- NCT05674929
- Locations
- π¬π§
Clerkenwell Health, London, United Kingdom
π¬π§King's College London, London, United Kingdom
An Open-Label, Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Beckley Psytech Limited
- Target Recruit Count
- 52
- Registration Number
- NCT05660642
- Locations
- π¬π§
MAC Clinical Research, Liverpool, United Kingdom
π¬π§Hammersmith Medicines Research, London, United Kingdom
π¬π§King's College London, Clinical Trials Facility, London, United Kingdom
Single Ascending Dose Study With BPL-003 in Healthy Subjects
Phase 1
Completed
- Conditions
- Pharmacokinetics in Healthy Adults
- Interventions
- Other: Placebo
- First Posted Date
- 2022-04-26
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Beckley Psytech Limited
- Target Recruit Count
- 62
- Registration Number
- NCT05347849
- Locations
- π¬π§
Hammersmith Medicines Research, London, United Kingdom
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
Phase 1
Completed
- Conditions
- Pharmacokinetics in Healthy Adults
- Interventions
- Other: Placebo
- First Posted Date
- 2021-09-02
- Last Posted Date
- 2022-10-12
- Lead Sponsor
- Beckley Psytech Limited
- Target Recruit Count
- 36
- Registration Number
- NCT05032833
- Locations
- π¬π§
King's College London, London, United Kingdom
Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)
Phase 1
Terminated
- Conditions
- Short Lasting Unilateral Neuralgiform Headache Attacks
- Interventions
- First Posted Date
- 2021-05-27
- Last Posted Date
- 2022-10-12
- Lead Sponsor
- Beckley Psytech Limited
- Target Recruit Count
- 4
- Registration Number
- NCT04905121
- Locations
- π¬π§
King's College London, London, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath